Drug Database
AR

articaine hydrochloride + epinephrine (Septocaine)

✓ Approved

GC corporation · 小分子 · 小分子

什么是 articaine hydrochloride + epinephrine?

articaine hydrochloride + epinephrine 是一种小分子,由GC corporation研发。该药已获批,用于治疗相关适应症,给药途径:Injectable (Others)。

药物档案

商品名Septocaine
公司GC corporation
药物类别小分子
给药途径Injectable (Others)
状态Approved

治疗适应症

articaine hydrochloride + epinephrine 针对 2 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Nervous system disordersAnaesthesia✓ Approved
Nervous system disordersSensory loss✓ Approved

相关研究文献

PubMedClinical oral investigations2026-11-19

Intra-sulcular compound chamomile and lidocaine hydrochloride gel for procedural pain during ultrasonic scaling: a randomized, single-blind, split-mouth, sham-controlled superiority trial in adults with plaque-induced gingivitis.

Tang Rong R, Yin Tingting T, Liang Jia J, Wang Ruijie R et al.

This study aimed to evaluate whether intra-sulcular application of a compound chamomile and lidocaine hydrochloride gel (Kami-Gel) reduces procedural pain during ultrasonic supragingival scaling in adults with plaque-induced gingivitis compared with a sham procedure. A single-center, randomized, single-blind, split-mouth, sham-controlled superiority trial was conducted involving 114 adults with plaque-induced gingivitis. Participants received a sequential split-mouth treatment. The test side received intra-sulcular application of Kami-Gel, while the control side received a sham application (mimicked injection). The primary outcome was procedural pain intensity measured on a 0-10 Visual Analog Scale (VAS). Secondary outcomes included the number of pain complaints, procedural duration, patient satisfaction, and plaque index (PI). Safety was assessed immediately and at 24 h. All 114 participants completed the study. Median VAS score was significantly lower in the test group (1.7 [IQR: 0.62-2.58]) than the control group (4.1 [IQR: 2.42-5.7]), with an estimated treatment difference of - 2.35 (95% CI: -3.0 to - 1.7)-the upper limit of which fell below the pre-specified superiority margin of - 1.2, confirming superiority (P < 0.001). The test group also demonstrated significantly fewer pain complaints (median 0 vs. 1), shorter procedural duration (median 10 vs. 12 min), and higher patient satisfaction (all P < 0.001). Post-scaling plaque index was significantly lower in the test group (median 0.75 [IQR: 0.55-0.86] vs. 0.89 [IQR: 0.75-0.96]; P < 0.001), though this difference may reflect improved patient cooperation rather than a direct pharmacological effect. No adverse events were reported. Intra-sulcular application of compound chamomile and lidocaine hydrochloride gel reduces procedural pain during ultrasonic supragingival scaling compared to a sham procedure. Its use was associated with shorter active scaling time and higher satisfaction. Whether these acute benefits translate to improved long-term periodontal treatment compliance warrants further investigation. Intra-sulcular application of compound chamomile and lidocaine gel (Kami-Gel) prior to ultrasonic supragingival scaling reduces procedural pain and was associated with higher patient satisfaction. A lower post-scaling plaque index was observed in the test group, potentially attributable to improved patient cooperation during instrumentation. This safe, non-injectable chairside technique provides clinicians a practical tool to enhance patient comfort during scaling procedures.

PMID 43052462
阅读全文 →
PubMedBMC oral health2026-11-19

Antibacterial efficacy of octenidine, sodium hypochlorite, and their combination against multispecies endodontic biofilms: an in vitro CLSM study.

Baştürk Özer Muazzez Naz MN, Çulha Emre E, Özer Hasan Yıldırım HY

The current study used confocal laser scanning microscopy (CLSM) to assess the antibacterial activity of octenidine hydrochloride (OCT) both by itself and in combination with sodium hypochlorite (NaOCl) on the eradication of biofilms. Forty dentin blocks were inoculated with a biofilm consisting of Enterococcus faecalis, Staphylococcus aureus, Pseudomonas aeruginosa, and Streptococcus mutans. After a 3-week incubation period, the resulting diverse biofilm was imaged using a scanning electron microscope (SEM). Five groups were formed: Saline solution (SS), 2% chlorhexidine (CHX), 5% NaOCl, undiluted OCT (containing 0.1% octenidine), and a 5% NaOCl / undiluted OCT mixture (90:10 ratio). Samples were subjected to the relevant agent for 5 min. The percentage of dead cell bacteria was evaluated using the Live/Dead BacLight Viability Kit dye under CLSM. Image analysis was performed with Image J software. The Kruskal-Wallis and Dunn's tests were used to statistically assess the data, with a significance threshold of p < 0.05. CLSM images showed that the NaOCl alone eliminated the amount of bacteria similar to NaOCl/OCT mixture group (p > 0.05) and significantly more bacteria compared to other solutions (p < 0.05). NaOCl/OCT mixture group was also similar to the OCT alone group (p > 0.05), while CHX and SS groups represented the least amount of dead bacteria than other groups (p < 0.05). Under the experimental conditions, the NaOCl/OCT combination demonstrated antibacterial activity comparable to NaOCl alone. While 5% NaOCl remained the most effective agent, the addition of OCT did not provide a statistically significant increase in antibacterial efficacy. SS and CHX exhibited significantly lower antibacterial effects.

PMID 43052949
阅读全文 →
PubMedFrontiers in pharmacology2026-11-18

Lidocaine modulates interleukin-1β and interferon-α2 secretion in LPS with ATP stimulated human peripheral blood mononuclear cells.

Oostwouder Cees-Jan CJ, Vos Karin K, Merkus Mathijs R MR, Tolsma Casper S CS et al.

Local anesthetics are canonically used for analgesia and anti-arrhythmic therapy, but increasing evidence indicates additional anti-inflammatory properties, including modulation of purinergic signalling. A recent retrospective observational cohort study indicated that subcutaneous lidocaine-Hydroxypropyl-β-cyclodextrin (HP-β-CD) was associated with sustained improvements in quality of life in patients with neuropathic pain in post-COVID, but the underlying mechanism remains to be established. The aim of this study was to determine whether lidocaine and articaine, alone or in combination with HP-β-CD, modulate in vitro immune cell activation and cytokine secretion in human peripheral blood mononuclear cells (PBMCs). PBMCs were stimulated using phytohemagglutinin (PHA), lipopolysaccharide (LPS), or LPS combined with adenosine triphosphate (ATP) to engage P2X-associated inflammatory pathways, and compounds were applied both prior to and following stimulation. Cytokine secretion was quantified using a 13-plex immunoassay and cell activation was assessed by flow cytometry. Lidocaine-containing formulations attenuated cytokine secretion most prominently under conditions engaging ATP-dependent signaling, reducing interleukin-1β and interferon-α2, with interleukin-1β suppression being the most consistent effect across stimulation conditions. Articaine showed less consistent immunomodulatory effects than lidocaine, which may reflect its previously reported lack of purinergic receptor inhibition, while HP-β-CD alone did not influence immune activation or cytokine release under any condition. Together, these findings show that lidocaine-containing treatments can modulate cytokine responses in human PBMCs, particularly under LPS with ATP stimulation. These findings identify lidocaine as a modulator of ATP-dependent inflammatory signaling.

PMID 43047804
阅读全文 →
PubMedFrontiers in aging2026-11-18

Effect of papaverine hydrochloride on functional visual acuity in non-arteritic central retinal artery occlusion: a retrospective cohort study.

Liu Zhongzhong Z, Lu Qingli Q, Liu Tong T, Peng Linna L et al.

Non-arteritic central retinal artery occlusion (NA-CRAO) is an acute ocular emergency that frequently results in severe and irreversible vision loss with limited therapeutic options. Papaverine hydrochloride, a non-specific vasodilator commonly used to relieve vasospasm, has not been previously evaluated for its potential benefits for visual recovery in patients with NA-CRAO. Therefore, this study aims to investigate the association between papaverine hydrochloride treatment (PHt) and functional visual acuity improvement in patients with NA-CRAO. Propensity-score matching was used to retrospectively collect clinical data of 104 NA-CRAO patients with similar baseline characteristics. The patients were categorized into a PHt group (n = 52) and a non-papaverine hydrochloride treatment (non-PHt) group (n = 52). The primary outcome was functional visual acuity (best-corrected visual acuity ≥20/100) assessed at discharge and at a 1-month follow-up. Logistic regression and subgroup analyses were performed to evaluate the associations between papaverine hydrochloride use and improvements in functional visual acuity. The PHt group showed significantly higher functional visual acuity than the non-PHt group at discharge (32.7% vs. 15.4%, p = 0.039) and at the 1-month follow-up (53.8% vs. 34.6%, p = 0.048). In adjusted models, treatment with papaverine hydrochloride was an independent favorable factor for improved functional visual acuity at discharge (odds ratio [OR] = 3.52, 95% confidence interval [CI]: 1.20-10.36, p = 0.022) and at the 1-month follow-up (OR = 3.15, 95% CI: 1.19-8.29, p = 0.020). Subgroup analyses demonstrated consistent therapeutic effects across age, sex, the side of the affected eye, intra-arterial thrombolysis and intravenous thrombolysis strata, with no statistically significant interaction effects identified at either time point (all Pinteraction >0.05). Treatment with papaverine hydrochloride was significantly associated with visual recovery in patients with NA-CRAO. Prospective further studies of causality are needed to validate these results and assess their safety.

PMID 43047374
阅读全文 →
PubMedThe Analyst2026-11-18

UV-activated nitrogen-doped carbon dots enable oxidase-mimicking catalysis for colorimetric epinephrine detection and ROS-mediated cancer cell killing.

Govindaraju Rajapriya R, Kim Jongsung J

Nanozymes are stable and low-cost enzyme mimics, but their modest intrinsic activity limits their performance in biosensing and biomedical applications. Here, we report photo-activatable nitrogen-doped carbon dots (PEICDs) synthesized via a one-pot hydrothermal method using citric acid, L-ascorbic acid, and polyethylenimine as carbon and nitrogen precursors. Under UV irradiation, the PEICDs exhibited markedly enhanced oxidase-like activity through ROS generation, enabling efficient 3,3',5,5'-tetramethylbenzidine oxidation and a strong colorimetric response. We exploited this behavior to develop an epinephrine sensor with a detection limit of 0.896 μM, high selectivity, and good recovery in spiked human serum samples. In addition, UV pre-activation before cell incubation enabled ROS-mediated cytotoxicity toward MCF-7 breast cancer cells while avoiding direct irradiation of the cells, demonstrating a simple strategy for externally controllable sensing and anticancer application.

PMID 43049359
阅读全文 →
PubMedBMC surgery2026-11-18

Risk factors for hemodynamic instability in patients with pheochromocytoma: a meta-analysis and systematic review.

Sun Zhipeng Z, Hong Baoan B, Bo Yuxuan Y, Zhang Ning N

Pheochromocytomas and paragangliomas (PPGLs), catecholamine - secreting tumors from the adrenal medulla, can cause hypertension and other hemodynamic abnormalities. Patients with PPGLs are prone to hemodynamic instability (HI) during and after surgery, which can impact treatment and prognosis, so it is crucial to identify HI risk factors. We searched multiple databases (Cochrane Library, Wanfang, Web of Science, PubMed, Embase, CNKI, and VIP) up to February 24, 2025. The Newcastle-Ottawa Scale was used to assess study quality. The Stata 15.0 software was used for meta-analyses with random-effects or fixed-effects models to calculate pooled odds ratios (ORs) or standardized mean differences (SMDs) with 95% confidence intervals (CIs). Twenty-three case-control studies involving 2,560 individuals were included. The following were identified as significant risk factors for HI in individuals with PPGLs: age [P = 0.000]; presence of PPGLs symptoms [P = 0.004]; history of diabetes mellitus [P = 0.004]; coronary artery disease (CAD) [P = 0.020]; preoperative α-blocker use [P = 0.001]; preoperative β-blocker use [P = 0.018]; tumor size [P = 0.000]; American Society of Anesthesiologists > II [P = 0.001]; mean 24 h urinary epinephrine [P = 0.003]; mean 24 h urinary norepinephrine [P = 0.024]; mean 24 h urinary metanephrine [P = 0.003]; mean 24 h urinary normetanephrine [P = 0.000]; normalized epinephrine/metanephrine [P = 0.000]; longer anesthesia duration [P = 0.044]; longer operative time [P = 0.025]. This study has found several risk factors for HI in PPGL patients, including older age, presence of PPGLs symptoms, history of diabetes or CAD, preoperative use of α-blocker or β-blocker, bigger tumor size, longer anesthesia durations and operation durations, ASA grade > II and bigger mean 24-hour urinary catecholamine metabolites. Clinicians should focus on these factors during perioperative management, develop individualized treatment plans to reduce HI risk, and enhance patient outcomes. Not applicable.

PMID 43046039
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多articaine hydrochloride + epinephrine